Department of Anesthesiology and Pain Medicine, Korea University Anam Hospital, Seoul, South Korea.
Department of Anesthesiology and Pain Medicine, Changwon Hanmaeum Hospital, Changwon, South Korea.
Transplant Proc. 2023 Nov;55(9):2143-2158. doi: 10.1016/j.transproceed.2023.08.012. Epub 2023 Oct 20.
Although liver transplantation (LT) is one of the definitive treatments for patients with end-stage liver failure, it inevitably results in ischemic reperfusion injury. It is known that prognosis is improved when temporary ischemic conditioning (IC) is applied to patients with ischemic reperfusion injury. The objective of this meta-analysis was to determine the short-term and long-term effects of IC on the clinical outcomes of LT recipients.
Randomized controlled studies on IC in patients with LTs were included. Patients were compared between an IC group and a sham group. Studies were retrieved from PubMed, Embase, and Cochrane Library. The risk of bias was evaluated using RoB 2.0. Mortality, graft function, and major complications were synthesized using RevMan 5.4.1.
Among 316 papers, 17 articles (1196 patients) were included. There was an insignificant increase in short-term mortality (risk ratio [RR]: 3.00, 95% CI: 0.32-28.14, P = .34). However, long-term mortality was lower in the IC group than in the sham group, but not significantly (RR: 0.75; 95% CI: 0.47-1.20, P = .23). Short-term graft function (acute graft rejection and primary graft non-function) was not improved by IC. One-year graft loss tended to show better results in the IC group (RR: 0.53, 95% CI: 0.26-1.07, P = .08).
Ischemic conditioning did not have a beneficial effect on LT. Although long-term outcomes appear to be better in the IC group than in the sham group, further randomized controlled trials are needed.
虽然肝移植(LT)是治疗终末期肝功能衰竭患者的一种确定性治疗方法,但不可避免地会导致缺血再灌注损伤。已知在发生缺血再灌注损伤的患者中应用临时缺血预处理(IC)可改善预后。本荟萃分析的目的是确定 IC 对 LT 受者临床结局的短期和长期影响。
纳入了关于 LT 患者 IC 的随机对照研究。将患者分为 IC 组和假手术组进行比较。研究从 PubMed、Embase 和 Cochrane Library 中检索。使用 RoB 2.0 评估偏倚风险。使用 RevMan 5.4.1 综合死亡率、移植物功能和主要并发症。
在 316 篇论文中,有 17 篇文章(1196 例患者)被纳入。短期死亡率无显著增加(风险比 [RR]:3.00,95% CI:0.32-28.14,P=.34)。然而,IC 组的长期死亡率低于假手术组,但无统计学意义(RR:0.75;95% CI:0.47-1.20,P=.23)。IC 不能改善短期移植物功能(急性移植物排斥和原发性移植物无功能)。IC 组 1 年移植物丢失倾向于显示更好的结果(RR:0.53,95% CI:0.26-1.07,P=.08)。
缺血预处理对 LT 没有有益作用。尽管 IC 组的长期结果似乎优于假手术组,但仍需要进一步的随机对照试验。